First Launch of the Hyris System bCube in Malta for detection of SARS-CoV-2

COVID has taken a huge toll in Malta and throughout the world. Apart from supplying various items related to COVID Protection, that help in the prevention, management and diagnosis of COVID,  Drugsales is now proud to launch the bCube in Malta.

The Hyris bCUBE is a revolutionary portable DNA-testing laboratory in a box, offering Point of Care (POC) testing wherever people are—anytime, anywhere. Controlled by any device with an internet connection, including a smartphone, the scientifically validated bCUBE analyzes test samples through a cloud-based platform that delivers accurate results in around 90 minutes.

The bCUBE deploys PCR (Polymerase Chain Reaction) technology which is considered the “gold standard” according to the CDC and the WHO testing guidelines.

The Hyris System™ can detect SARS-CoV-2 despite all the novel variants:

As the new mutations of SARS-CoV-2 keep spreading world-wide, significant concerns increasingly worry both citizenship and the institutions. Even if some of these variants are relatively innocuous, others may give the virus a selective advantage. Based on a risk assessment by major authorities involved in the fight against the spread of COVID-19, such as WHO, ECDC, CDC, these mutations are identified as Variants of Concern and monitored, alerting even more globally scientific and medical communities.

This system, proudly distributed in Malta by Drugsales Ltd, will provide our customers with a huge advantage in the diagnosis and treatment of COVID-19.